SOFIA (Bulgaria), December 11 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Wednesday that its CEO Ognyan Donev has acquired 2,164 shares in the company at a weighted average price of 3.4338 levs ($1.94/1.75 euro) per share.